Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2024; 14(2): 273-280


Identification of bioactive compounds and ADMET profile of stem bark of Syzygium samarangense and their potential as antibreast cancer and antiinflammatory

Ahmad Misbakhus Sururi, Tukiran Tukiran, Elvira Ratna Aisa, Muhammad Raihan.




Abstract

Syzygium samarangense is a potential herbal plant that can be developed in the medical world. Research related to the use of this plant in the medical world has varied, but the stem bark of the plant is rarely developed. This study aimed to identify the chemical constituents of S. samarangense stem bark and its bioactivity as anticancer and anti-inflammatory in silico. The research method started with extracting and identifying bioactive compounds through liquid chromatography mass spectrometry, followed by molecular docking with Human epidermal growth factor receptor-2 receptors (anticancer targets) and COX-2 (anti-inflammatory targets), as well as absorption, distribution, metabolism, excretion, and toxicity (ADMET) pharmacokinetic analysis. The results showed that this plant’s methanol extract contained 60 bioactive compounds with three potential anticancer and anti-inflammatory compounds: kaempferol-7-rhamnoside-4′-glucoside, syzyginin B, and casuarinin. ADMET analysis displayed that they have similar ADMET profiles, with a potential compound as anti-breast cancer and anti-inflammatory, especially syzyginin B. Further research for the compound is needed, such as in vitro and in vivo, to develop its potential.

Key words: casuarinin, kaempferol-7-rhamnoside-4'-glucoside, syzyginin B, Syzygium samarangense






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.